Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS
RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research
RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.
Groundbreaking Gene Therapy for Retinal Disease
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
RPB and AAO Award Grants for Big Data Research to Advance Patient Care
Award recipients to use IRIS Registry database to conduct population-based studies.
Research to Prevent Blindness Expands Grants Program
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
Study Tests Stem Cell-based Therapy for Advanced Dry AMD
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
Study Links Aging Immune Cells and AMD
RPB-supported researchers at Washington University School of Medicine in St. Louis published the new findings.
The National Eye Institute Turns 50
RPB celebrates five decades of sight-saving discoveries at NEI.
Vision Funders Collaborate for Impact
RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.
RPB and AAO Announce New Grant Opportunities to Support Vision Research
Partnership to utilize IRIS Registry database to advance patient care.
Reversing Retinal Degenerative Diseases: We’re One Step Closer
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
Understanding Usher Syndrome: New Findings
RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.
New Stem Cell Model Replicates Macular Degeneration
The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.
Researchers ID Key Compounds Related to Blood Vessel Growth in Wet AMD
The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world
RPB-supported Researchers ID Master Molecule behind Corneal Inflammation
RPB-supported researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that triggers inflammation during and even after a herpes virus infection.
Electric Fields ‘Steer’ Neural Stem Cells
New RPB-supported research provides hope for transplants of neural stem cells as future treatment for brain injuries.
July is Dry Eye Awareness Month
Dry eye, a global problem affecting more than 30 million people in the U.S. alone, occurs when the eye does not produce tears properly or when the tears are not of the correct consistency and evaporate too quickly.
Researchers Identify Biomarker for Glaucoma Damage
The RPB-supported researchers hope their finding will lead to tests to identify cell damage before irreversible vision loss.
Working Together to Fund Scientific Research for Eye Health
More than 30 private and public funders of vision research came together in Washington DC to discuss ways to maximize their support of scientific research in light of new recommendations and a changing environment.
Making the case that ‘Science Is For All’
An RPB Trustee pens a powerful Op-Ed on the need to support scientific research through the National Institutes of Health.
RPB AWARDS $5.4 MILLION IN GRANTS
The latest grant cycle supports eye research related to a variety of diseases and conditions.
Natural Compound Reduces Signs of Aging, Including Eye Dryness
RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice.
Emerging Vision Scientists Visit Capitol Hill
Twenty-two emerging vision scientists conducted Capitol Hill visits with NAEVR and RPB to champion federal funding for critical vision research.
Researchers Identify Treatment Target for Blinding Retinal Diseases
A common pathway involved in photoreceptor death has been identified in retinitis pigmentosa, advanced dry age-related macular degeneration and other retinal diseases, with early evidence of a possible halt to vision loss related to pathway treatment.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Research Scientists & Grantees | Eye Care Specialists | Donors & Partners |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2018 Research to Prevent Blindness. All Rights Reserved.
